Pressure BioSciences (OTCQB: PBIO), a Massachusetts-based company that manufactures high pressure-based equipment and laboratory instrumentation for the life sciences industry, has been working with The Ohio State University College of Food, Agricultural, and Environmental Sciences (“CFAES”) to develop new technology to preserve clean-label liquid food without artificial preservatives. The innovative manufacturing tech is called BaroShear MAX ultra shear technology (“UST”). According to a recent announcement, researchers in Ohio State’s CFAES departments of food science and technology, along with Food, Agricultural and Biological Engineering (“FABE”) have installed and commissioned the technology, which preserves foods and beverages using wholesome, recognizable ingredients. In addition, the tech doesn’t use any artificial preservatives and relies on reduced heat. The researchers also plan to launch an outreach program whereby food and beverage companies that join the Food Industry Consortium can use the new technology. “The ability to modify products through UST-directed physical stress will create many new opportunities in the commercialization of liquid foods and beverages, as well as in such enormous markets as nutraceuticals, cosmetics, and pharmaceuticals,” said Pressure BioSciences senior VP Edmund Ting in the press release. “UST not only can produce the highest quality nanoemulsions, but this innovative process can also help destroy bacteria and other pathogens, and reduce or eliminate the need for chemical additives, thus increasing food safety and quality. . . . Mechanically, the food is subjected to high shear, reducing the size of the droplets so small that they stay in suspension, eliminating or reducing the need for additive stabilizers. High pressure also promotes beneficial changes in viscosity for certain starch or protein products.”
To view the full press release, visit https://ibn.fm/1h1aM
About Pressure BioSciences Inc.
Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. PBIO’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented-enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control biomolecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is on the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of PBIO’s pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company website at www.PressureBioSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
